Signs and symptoms indicative of community-acquired pneumonia in infants under six months

Maria de Fátima Bazhuni Pombo March1, Clemax Couto Sant'Anna

  • 1Martagão Gesteira Pediatric Institute, Dept. of Pediatrics, Medical School, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Insights

Clinical signs and symptoms do not reliably distinguish bacterial from viral pneumonia in young children. The findings support Brazil's national program for early pneumonia diagnosis, regardless of the cause.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Pneumonia is a leading cause of mortality in children under five.
  • Differentiating between bacterial and viral pneumonia is crucial for appropriate treatment.
  • The Brazilian National Control Program for Acute Respiratory Infections (ARI) aims for early pneumonia diagnosis.

Purpose of the Study:

  • To evaluate clinical signs and symptoms for predicting bacterial versus viral pneumonia in infants.
  • To assess the efficacy of these indicators in the context of the Brazilian ARI program.

Main Methods:

  • An observational prospective study involving 76 infants (birth to 6 months) with pneumonia.
  • Patients were categorized into bacterial (n=47) or viral (n=29) pneumonia based on radiological findings.
  • Frequencies, sensitivities, and specificities of various clinical signs and symptoms were analyzed.

Main Results:

  • No specific clinical signs or symptoms reliably differentiated bacterial from viral pneumonia.
  • Fever, hypoactivity, and prostration showed varying sensitivities and specificities in both groups.
  • Respiratory findings like cough, respiratory rate, auscultation, and chest indrawing also lacked distinct predictive value for etiology.

Conclusions:

  • Clinical presentation alone is insufficient to distinguish bacterial from viral pneumonia in infants.
  • The findings support the Brazilian ARI program's approach to early pneumonia diagnosis, irrespective of the causative agent.
  • This reinforces the program's adequacy in managing pediatric pneumonia effectively.
Abstract

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...